Intermolecular, Inc.
IMI
IMI was delisted on the 19th of September, 2019.
0 hedge funds and large institutions have $0 invested in Intermolecular, Inc. in 2019 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 39 closing their positions.
100% less funds holding
Funds holding: 40 → 0 (-40)
100% less capital invested
Capital invested by funds: $35.5M → $0 (-$35.5M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 39
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
Raging Capital Management
Rocky Hill,
New Jersey
|
-$17.2M |
| 2 |
GLAM
Gardner Lewis Asset Management
Chadds Ford,
Pennsylvania
|
-$5.35M |
| 3 |
GF
Gabelli Funds
Rye,
New York
|
-$2.42M |
| 4 |
Renaissance Technologies
New York
|
-$1.85M |
| 5 |
GCIA
Gabelli & Co Investment Advisers
Rye,
New York
|
-$1.66M |
IMI Hedge Fund Activity: Q3 2019 in Review
0 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Intermolecular, Inc. (IMI) for Q3 2019, worth a combined $0 — down 100% from $35.5M a quarter earlier.
Sellers outnumbered buyers: 39 funds closed out of IMI and 0 opened new positions — a net loss of 39 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Raging Capital Management, exiting entirely with an estimated $17.2M sold.
- 0 institutional investors held Intermolecular, Inc. (IMI) as of Q3 2019, down from 40 in Q2 2019.
- Funds reported $0 of Intermolecular, Inc. stock for Q3 2019, down 100% quarter-over-quarter.
- 0 funds opened new Intermolecular, Inc. positions in Q3 2019 and 39 closed out, a net change of -39 holders.
- The largest Intermolecular, Inc. seller in Q3 2019 was Raging Capital Management, an estimated $17.2M sold.
Based on aggregated 13F filings for Q3 2019.